Torrent Pharmaceuticals Limited — Updates, 10-04-2026: General Updates
10-04-2026 | 07:07 pm
10-04-2026 | 07:07 pm
Torrent Pharma's Bileshwarpura (Oncology) facility passed its USFDA inspection with zero observations. This positive outcome signals strong compliance and quality controls, reducing regulatory risk and supporting business continuity.
No comments yet. Be the first to comment!
